Use of bisphosphonates in cancer patients

被引：68

作者：

Body, JJ

Coleman, RE

Piccart, M

机构：

[1] FREE UNIV BRUSSELS, INST JULES BORDET, SUPPORT CARE CLIN, B-1000 BRUSSELS, BELGIUM

[2] FREE UNIV BRUSSELS, INST JULES BORDET, CLIN CHEMOTHERAPY, B-1000 BRUSSELS, BELGIUM

[3] UNIV SHEFFIELD, WESTON PARK HOSP, YCRC DEPT CLIN ONCOL, SHEFFIELD S5 7AU, S YORKSHIRE, ENGLAND

来源：

CANCER TREATMENT REVIEWS | 1996年 / 22卷 / 04期

关键词：

D O I：

10.1016/S0305-7372(96)90020-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：265 / 287

页数：23

共 102 条

[11] MEDICAL-TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA AND TUMOR-INDUCED OSTEOLYSIS - CHALLENGES FOR FUTURE-RESEARCH [J].

BODY, JJ .

SUPPORTIVE CARE IN CANCER, 1993, 1 (01) :26-33

[12] DOSE-RESPONSE STUDY OF AMINOHYDROXYPROPYLIDENE BISPHOSPHONATE IN TUMOR-ASSOCIATED HYPERCALCEMIA [J].

BODY, JJ ;

POT, M ;

BORKOWSKI, A ;

SCULIER, JP ;

KLASTERSKY, J .

AMERICAN JOURNAL OF MEDICINE, 1987, 82 (05) :957-963

[13]

BODY JJ, 1995, J BONE MINER RES, V10, P1191

[14] TREATMENT OF MALIGNANCY-ASSOCIATED HYPERCALCEMIA WITH INTRAVENOUS AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE [J].

BODY, JJ ;

BORKOWSKI, A ;

CLEEREN, A ;

BIJVOET, OLM .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) :1177-1183

[15] URINARY PYRIDINIUM CROSS-LINKS AS MARKERS OF BONE-RESORPTION IN TUMOR-ASSOCIATED HYPERCALCEMIA [J].

BODY, JJ ;

DELMAS, PD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :471-475

[16]

BODY JJ, 1995, SUPPORT CARE CANCER, V3, P355

[17]

BODY JJ, 1996, OSTEOPOROSIS INT S1, V6, P247

[18] BONE AND RENAL COMPONENTS IN HYPERCALCEMIA OF MALIGNANCY AND RESPONSES TO A SINGLE INFUSION OF CLODRONATE [J].

BONJOUR, JP ;

PHILIPPE, J ;

GUELPA, G ;

BISETTI, A ;

RIZZOLI, R ;

JUNG, A ;

ROSINI, S ;

KANIS, JA .

BONE, 1988, 9 (03) :123-130

[19]

BOUIZAR Z, 1993, CANCER RES, V53, P5076

[20] PARATHYROID-HORMONE RELATED PROTEIN AND SKELETAL MORBIDITY IN BREAST-CANCER [J].

BUNDRED, NJ ;

WALKER, RA ;

RATCLIFFE, WA ;

WARWICK, J ;

MORRISON, JM ;

RATCLIFFE, JG .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :690-692

← 1 2 3 4 5 6 7 8 9 10 →